Conventional therapy for moderate to severe inflammatory bowel disease: A systematic literature review

doi:10.3748/wjg.v25.i9.1142

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 25, Issue 9

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (15022)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-1) series, Tables (1-16) series.

Item

Count

PDF

1440

WORD

398

HTML

8620

Figures (1-1)

251

Tables (1-16)

502

Sum=11211

Featured Article

The chart showing Browse series, Download series.

Item

Count

Browse

713

Download

648

Sum=1361

Publishing Process of This Article

Item

Count

Browse

1041

Download

1409

Sum=2450

Mar 7, 2019 (publication date) through Sep 20, 2024

Times Cited of This Article

Times Cited (57)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Systematic Reviews

World J Gastroenterol. Mar 7, 2019; 25(9): 1142-1157
Published online Mar 7, 2019. doi: 10.3748/wjg.v25.i9.1142

Table 6 Meta-analyses included for induction of mucosal healing in Crohn’s disease

Study	Intervention	Comparator	Follow-up	n	Mucosal healing, RR (95%CI)	Quality of evidence
Chande et al[23]	AZA	IFX	26 wk	214	RR 0.55 (0.33-0.94)¹	Moderate

¹Mucosal healing was defined as the absence of mucosal ulceration at week 26 in patients who had confirmed mucosal ulceration at baseline. AZA: Azathioprine; CI: Confidence interval; IFX: Infliximab; n: Number of patients; RR: Risk ratio.

Citation: Damião AOMC, Azevedo MFC, Carlos AS, Wada MY, Silva TVM, Feitosa FC. Conventional therapy for moderate to severe inflammatory bowel disease: A systematic literature review. World J Gastroenterol 2019; 25(9): 1142-1157
URL: https://www.wjgnet.com/1007-9327/full/v25/i9/1142.htm
DOI: https://dx.doi.org/10.3748/wjg.v25.i9.1142